Top Gainer for 11-16-22: $INM
$INM - InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding: https://finance.yahoo.com/news/inmed-pharmaceuticals-advances-neurodegenerative-disease-120000406.html